ALLURION科技公司发布初步结果,展示其项目与低剂量Tirzepatide联合应用以优化肌肉量和GLP-1依从性
ALLURION科技公司发布初步结果,展示其项目与低剂量Tirzepatide联合应用以优化肌肉量和GLP-1依从性
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.